Concepedia

The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats

Len Verbeke, Ricard Farré, Bert Verbinnen, Kris Covens, Tim Vanuytsel, Jan Verhaegen, Mina Komuta, Tania Roskams, Sagnik Chatterjee, Pieter Annaert,

American Journal Of Pathology · 2015 · 209 citations · 45 references

DOIFull text

Open access

Concepts

References

45

Analyzing real-time PCR data by the comparative CT method

Thomas D. Schmittgen, Kenneth J. Livak · Nature Protocols · 2008 · 26.7K citations

, , +3

Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

Richard Moreau, Rajiv Jalan, Pere Ginès et al. · Gastroenterology · 2013 · 3K citations

, , +11

Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Sunder Mudaliar, Robert R. Henry, Arun J. Sanyal et al. · Gastroenterology · 2013 · 915 citations

, , +12

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

Raffaella Maria Gadaleta, Karel J. van Erpecum, Bas Oldenburg et al. · Gut · 2011 · 851 citations

, , +17

Translocation of Certain Indigenous Bacteria from the Gastrointestinal Tract to the Mesenteric Lymph Nodes and Other Organs in a Gnotobiotic Mouse Model

Rodney D. Berg, Alva W. Garlington · Infection and Immunity · 1979 · 846 citations · Full text

, , +7